Cingulate (CING) announced that it held a Pre-NDA meeting with the U.S. Food and Drug Administration, FDA, yesterday to discuss the submission ...

Laila Maidan is a Tech and Investing reporter at MarketWatch. She covers the rapid developments in the sector along with actionable investment recommendations and deep dives into valuations.